Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targeted Ultrasound in Rheumatoid Arthritis (TURA)
2013-002777-22Phase 4Terminated
- Sponsor
- University of Leeds
- Start
- Oct 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4 trial of adalimumab in rheumatoid arthritis (RA), sponsored by University of Leeds. Started Oct 2013; status: terminated.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2013-002777-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002777-22.